Less Burdensome Growth-Hormone Replacement With Once-Weekly Somapacitan in Children

For replacement of endogenous growth hormone in children with growth-hormone deficiency, a once-weekly injection somapacitan was safe and effective over 3 years in a phase 2 randomized controlled trial.
Reuters Health Information

source https://www.medscape.com/viewarticle/965864?src=rss